Aortic valve replacement in a patient with sickle cell disease—Are we justified to perform surgery in the TAVI era?

Abstract

Abstract Not all variants of SCD need the same management and this should be decided on a case‐by‐case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.

Keywords

• cardiopulmonary bypass
• cardiothoracic surgery
• hemotology
• sickle cell disease